LoadingLoadingLoadingNet buying: insiders sold $0 and bought $9.5M on the open market in 90 days (SEC Form 4). Congress: net selling of $90K to $323K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (1)
Two Sigma
$235.7M
added
Sells/Trims (2)
Viking Global
$239.3M
sold
Point72
$215.8M
trimmed
Buys (3)
Morano Susan E
$100K
bought
Habiger David C
$100K
bought
Mahoney Michael F
$9.0M
bought
No tracked top-trader positions in BSX as of Oct 24, 04:07 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Jul 29, 2026
Financial period
Q2 2026
Earnings per share
$0.83 expected
Revenue
Company release
Estimates as of Oct 24, 2026
EPS expected
$0.58 to $0.82
Revenue expected
24 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | $0.86 / $0.83Yahoo Finance | +3.86% beat | $5.44B No estimate | Unavailable |
| Mar 31, 2026 | Apr 22, 2026 | $0.80 / $0.79Yahoo Finance | +1.62% beat | $5.20B No estimate | Unavailable |
| Dec 31, 2025 | Feb 4, 2026 | $0.80 / $0.78Yahoo Finance | +2.43% beat | $5.29B No estimate | Unavailable |
| Sep 30, 2025 | Oct 22, 2025 | $0.75 / $0.71Yahoo Finance | +5.09% beat | $5.07B No estimate | Unavailable |
| Jun 30, 2025 | Jul 23, 2025 | $0.75 / $0.73Alpha Vantage | +2.74% beat | $5.06B No estimate | Unavailable |
| Mar 31, 2025 | Apr 23, 2025 | $0.75 / $0.67Alpha Vantage | +11.94% beat | $4.66B No estimate | Unavailable |
| Dec 31, 2024 | Feb 5, 2025 | $0.70 / $0.66Alpha Vantage | +6.06% beat | $4.56B No estimate | Unavailable |
| Sep 30, 2024 | Oct 23, 2024 | $0.63 / $0.59Alpha Vantage | +6.78% beat | $4.21B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $5.07B | $5.29B | $5.20B | $5.44B |
| Cost of what it sold | $1.52B | $1.35B | $1.59B | $1.59B |
| Gross profit | $3.54B | $3.94B | $3.61B | $3.85B |
| What it spent | ||||
| Research and development | $514.0M | $569.0M | $516.0M | $554.0M |
| Sales and admin | $1.74B | $1.83B | $1.78B | $1.80B |
| Other operating costs | $237.0M | $328.0M | $244.0M | $313.0M |
| Total operating expenses | $2.49B | $2.73B | $2.54B | $2.67B |
| What was left | ||||
| Operating profit | $1.05B | $1.21B | $1.07B | $1.18B |
| Interest on debt | $87.0M | $90.0M | $90.0M | $96.0M |
| Profit before tax | $939.0M | $700.0M | $1.16B | $1.06B |
| Tax | $183.0M | $31.0M | -$176.0M | $155.0M |
| Net profit | $755.0M | $668.0M | $1.34B | $907.0M |
| EBITDA | $1.37B | $1.16B | $1.60B | $1.51B |
This stock is trending upward.
Trend
Constructive
75 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bullish
Burlington biotech cuts nearly half its staff to focus on weight maintenance device
NeutralOct 22Boston Scientific Corp. stock outperforms competitors on strong trading day
BullishOct 22J&J, Medtronic present pulsed field ablation data from global real-world use
NeutralOct 22Edwards Lifesciences faces stock risk ahead of trial results says Stifel
Leans bearishOct 22Medtronic announces positive results from real-world registries for the Sphere-9 catheter and PulseSelect PFA System at APHRS 2026
Leans bullishOct 22Medtronic announces positive results from real-world registries for the Sphere-9™ catheter and PulseSelect™ PFA System at APHRS 2026
Leans bullishOct 22Honeywell Technologies expands AI complaint processing for life sciences
Leans bullishOct 22Boston Scientific Corp. stock underperforms Wednesday when compared to competitors
BearishOct 2133 macro signals shaping BSX right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
